Prolyl hydroxylase inhibitors and methods of use

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9598370
SERIAL NO

14854080

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AKEBIA THERAPEUTICS INC245 FIRST STREET SUITE 1400 CAMBRIDGE MA 02142

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boyer, Angelique Sun West Chester, US 18 488
Evdokimov, Artem G Foristell, US 44 487
Greis, Kenneth D Fort Thomas, US 16 336
Kawamoto, Richard Masaru Divide, US 22 586
Warshakoon, Namal C Cary, US 15 336
Wu, Shengde West Chester, US 20 359

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 21, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00